Among different Nmnat isoforms, we identified hNmnat1 as a potent inhibitor for APP aggregation as evidenced by a remarkable reduction of the processed APP-CTF and decreased number and size of amyloid plaques in the brain. Here, APP is linked to amyloidosis.